Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Robert Kagle currently holds 7,220,666 shares of 1Life Healthcare Inc (ONEM), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Robert Kagle has been a net seller of ONEM stock. They have purchased $0 and sold $39.4M worth of shares.
Robert Kagle's most recent insider trade was on Jun 14, 2021, when they sold 7,220,666 shares at $0.00 per share.
Robert Kagle serves as Executive at 1Life Healthcare Inc (ONEM). They have executed 111 insider transactions totaling $39.4M over their tenure at the company.
Robert Kagle holds the position of Executive at 1Life Healthcare Inc, where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 19 years and currently hold a stake valued at $0.
Robert Kagle has shown a selling trading pattern, with $0 in total purchases and $39.4M in total sales across all transactions. Their most recent activity indicates a tendency to reduce their position.
The largest transaction by Robert Kagle was on Sep 30, 2020, when they sold $9.2M worth of ASAN shares. This transaction involved 339,452 shares at $27.13 per share.
Robert Kagle currently owns 7,220,666 shares of 1Life Healthcare Inc (ONEM), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Robert Kagle's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Robert Kagle has 111 Form 4 filings on record as an insider at 1Life Healthcare Inc.
Set alerts for Robert Kagle and 40,000+ other insiders.